• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位肝移植后的重症监护病房结局:单中心经验及文献综述

Intensive care unit outcomes following orthotopic liver transplantation: single-center experience and review of the literature.

作者信息

Damaskos C, Kaskantamis A, Garmpis N, Dimitroulis D, Mantas D, Garmpi A, Sakellariou S, Angelou A, Syllaios A, Kostakis A, Lampadariou E, Floros I, Revenas K, Antoniou E A

出版信息

G Chir. 2019 Nov-Dec;40(6):463-480.

PMID:32007108
Abstract

BACKGROUND/AIM: Orthotopic Liver Transplantation (OLT) is the treatment of choice for patients with end stage liver disease, acute liver failure, hepatocellular carcinoma and metabolic disorders. As a result of improvement in surgical and anesthesiological skills, advanced understanding of transplant immunology and better critical care management of complications, patients survive longer after liver transplantation. It has been gradually achieved one-year survival rates of 80-90%. During the early post-operative period, all patients undergoing OLT are admitted to the intensive care unit, as they need a management of both preexisting patient's conditions and post-operative complications, usually due to either adverse intra-operative or post-operative events. The purpose of this review is the detailed recording, understanding and interpretation of immediate post-operative complications occurred in patients undergoing OLT, in intensive care unit. This could help to improve patient's treatment and reduce the incidence of complications, with further reduction of morbidity-mortality and cost. We also present our experience from the first 32 OLT patients from Liver Transplantation Unit of Laiko General Hospital, the only Liver Transplantation Unit in Athens.

MATERIALS AND METHODS

This literature review was performed using the MEDLINE database. The key words were; Orthotopic liver transplantation; intensive care unit; post-operative complications; outcomes. One hundred-sixteen articles published in English until 2018 were used. We also use all the results from our 32 patients from our Liver Transplantation Unit during the period 07/2006 to 07/2009.

RESULTS

All patients undergoing OLT admitted to the intensive care unit for a period of time, depending on the occurrence of post-operative complications. The incidence of primary failure ranges between 2-14%, whereas post-operative bleeding ranges between 7-15%. The treatment is usually conservative, although surgical repair may need in 10-15%. Acute renal failure post-operative is not an infrequent problem too, and has been reported to occur in 9% to 78% of cases. Acute rejection normally occurs 7-14 days after OLT. Additionally, the delay of the weaning from mechanical ventilation in the immediate post-operative period could increase the complications. Infectious complications are quite common almost from the first post-operative day in intensive care unit.

CONCLUSIONS

Prolonged intensive care stay could increase the complications post-operative Infectious complications, renal and respiratory impairment are among the most common causes of early post-transplant morbidity and mortality.

摘要

背景/目的:原位肝移植(OLT)是终末期肝病、急性肝衰竭、肝细胞癌和代谢紊乱患者的首选治疗方法。由于手术和麻醉技术的改进、对移植免疫学的深入理解以及对并发症更好的重症监护管理,肝移植患者的存活时间更长。目前已逐渐实现了80%至90%的一年生存率。在术后早期,所有接受OLT的患者都被收入重症监护病房,因为他们需要对患者术前状况和术后并发症进行管理,这些并发症通常是由术中或术后不良事件引起的。本综述的目的是详细记录、理解和解释在重症监护病房接受OLT的患者术后立即出现的并发症。这有助于改善患者的治疗并降低并发症的发生率,进一步降低发病率、死亡率和成本。我们还介绍了雅典唯一的肝移植单位——拉伊科综合医院肝移植科首批32例OLT患者的经验。

材料与方法

本综述使用MEDLINE数据库进行。关键词为:原位肝移植;重症监护病房;术后并发症;结果。使用了截至2018年以英文发表的116篇文章。我们还使用了2006年7月至2009年7月期间我们肝移植科32例患者的所有结果。

结果

所有接受OLT的患者都要在重症监护病房住院一段时间,具体取决于术后并发症的发生情况。原发性移植肝无功能的发生率在2%至14%之间,而术后出血的发生率在7%至15%之间。治疗通常是保守的,不过10%至15%的患者可能需要手术修复。术后急性肾衰竭也并非罕见问题,据报道其发生率在9%至78%的病例中出现。急性排斥反应通常在OLT术后7至14天发生。此外,术后早期脱机延迟会增加并发症。感染性并发症在重症监护病房几乎从术后第一天起就很常见。

结论

延长重症监护时间会增加术后并发症。感染性并发症、肾脏和呼吸功能损害是移植后早期发病和死亡的最常见原因。

相似文献

1
Intensive care unit outcomes following orthotopic liver transplantation: single-center experience and review of the literature.原位肝移植后的重症监护病房结局:单中心经验及文献综述
G Chir. 2019 Nov-Dec;40(6):463-480.
2
[Liver transplantation in adults: postoperative management and development during the first months].[成人肝移植:术后首个月的管理与进展]
Ann Fr Anesth Reanim. 1989;8(5):497-517. doi: 10.1016/s0750-7658(89)80017-6.
3
Acute renal failure following liver transplantation with induction therapy.肝移植诱导治疗后急性肾衰竭
Clin Nephrol. 2006 Feb;65(2):103-12. doi: 10.5414/cnp65103.
4
Orthotopic liver transplantation in critically ill cirrhotic patients with multi-organ failure: a single-center experience.多器官功能衰竭的重症肝硬化患者原位肝移植:单中心经验
Transplant Proc. 2011 Dec;43(10):3762-8. doi: 10.1016/j.transproceed.2011.08.110.
5
Acute kidney injury after orthotopic liver transplantation.原位肝移植术后急性肾损伤
Transplant Proc. 2012 Nov;44(9):2727-9. doi: 10.1016/j.transproceed.2012.09.096.
6
[Diagnosis and treatment of hepatic artery thrombosis after liver transplantation].[肝移植术后肝动脉血栓形成的诊断与治疗]
Chir Ital. 2000 Sep-Oct;52(5):505-25.
7
Acute renal failure and renal replacement therapy in the postoperative period of orthotopic liver transplant patients versus nonelective abdominal surgery patients.原位肝移植患者与非选择性腹部手术患者术后急性肾衰竭及肾脏替代治疗情况对比
Transplant Proc. 2011 May;43(4):1145-7. doi: 10.1016/j.transproceed.2011.02.051.
8
Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience.原位肝移植术后急性肾衰竭的危险因素:单中心经验
Transplant Proc. 2014 Oct;46(8):2786-9. doi: 10.1016/j.transproceed.2014.09.044.
9
Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation.肝移植术后急性肾衰竭中终末期肝病评分与简化急性生理学评分标准的模型
Transplant Proc. 2011 May;43(4):1139-41. doi: 10.1016/j.transproceed.2011.02.045.
10
A simplified multivisceral transplantation procedure for patients with combined end-stage liver disease and type 2 diabetes mellitus.一种简化的多脏器联合移植术式,用于治疗合并终末期肝病和 2 型糖尿病的患者。
Liver Transpl. 2017 Sep;23(9):1161-1170. doi: 10.1002/lt.24774.

引用本文的文献

1
A nomogram for predicting early bacterial infection after liver transplantation: a retrospective study.预测肝移植术后早期细菌感染的列线图:一项回顾性研究
Front Med (Lausanne). 2025 Apr 10;12:1563235. doi: 10.3389/fmed.2025.1563235. eCollection 2025.
2
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients.从列表到恢复:肝移植患者营养状况评估和管理综述。
Nutrients. 2023 Jun 16;15(12):2778. doi: 10.3390/nu15122778.
3
FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?
FDA 批准用于不可切除肝细胞癌的单克隆抗体:目前我们了解多少?
Int J Mol Sci. 2023 Jan 31;24(3):2685. doi: 10.3390/ijms24032685.
4
Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead-A Systematic Review.针对肝细胞癌治疗的靶向治疗:新时代的到来——系统评价。
Int J Mol Sci. 2022 Nov 15;23(22):14117. doi: 10.3390/ijms232214117.
5
Association of different central venous pressure levels with outcome of living-donor liver transplantation in children under 12 years.不同中心静脉压水平与 12 岁以下儿童活体肝移植结局的关系。
World J Pediatr. 2023 Feb;19(2):170-179. doi: 10.1007/s12519-022-00632-3. Epub 2022 Nov 18.
6
Liver Transplantation and Budd-Chiari Syndrome: When the Cause Becomes the Solution.肝移植与布加综合征:病因如何成为解决方案。
Maedica (Bucur). 2022 Jun;17(2):415-419. doi: 10.26574/maedica.2022.17.2.415.
7
The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma.SNHG15在肝细胞癌发病机制中的作用
J Pers Med. 2022 May 6;12(5):753. doi: 10.3390/jpm12050753.